EN/CN

About Us

Headquartered in Hong Kong, Great Bay Bio (GBB) is a high-tech enterprise dedicated to applying artificial intelligence and other cutting-edge technologies to the development of biopharmaceuticals and other blue ocean bio-products. GBB aims to ultimately solve numerous pain-points found in the biopharmaceutical industry, including high failure rates, long development timeline and high costs. Since establishment, the company has obtained massive drug development data from its 3100m²international level CMC facility. Prior, GBB has successfully brought a number of biologic products to NDA stage, some of which are classified as national class I innovative drugs. Currently, the company has created an intelligent centralized database, where deep learning is being performed to create a next generation AI-enabled bioprocessing ecosystem. ...

Learn More

What We Do

AI Enabled Biotechnology Development Platform

Learn More

Klone4.0TM

AI-enabled Cell Line Development Platform

Obtaining High Producers Actively and Accurately

AlfaStaXTM

AI-enabled Cell Line Stability Prediction Platform

Cell lines stability at 90 days can be predicted at 15 days

AlfaMedX®

AI-enabled Culture Media Development Platform

Providing Customized Media Formulation Faster at Lower Cost

Partners

  • (+852)3102 3232